George Demiris1, Debra Parker Oliver2, Karla Washington2, Kenneth Pike3. 1. School of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania. 2. School of Medicine, University of Missouri, Columbia, Missouri. 3. School of Nursing, University of Washington, Seattle, Washington.
Abstract
OBJECTIVES:Family caregivers of hospice patients have multiple needs as they try to cope during a stressful time. Translatable interventions effective in improving caregiver outcomes are greatly needed. Our objective was to assess the impact of a problem-solving intervention (called Problem-Solving Intervention to Support Caregivers in End-of-Life Care Settings [PISCES]) to support hospice caregivers on caregiver quality of life and anxiety, and compare its effectiveness delivered face to face and via videoconferencing. DESIGN: In this 4-year randomized clinical trial, caregivers were randomly assigned to a group receiving standard care with added "friendly calls" (attention control [AC] group), a group receiving standard care and PISCES delivered face to face (F2F), or a group receiving standard care and PISCES delivered via videoconferencing (VC). SETTING: Home hospice. PARTICIPANTS: A total of 514 caregivers participated (172 in AC, 171 in F2F, and 171 in VC). Caregivers were predominantly female (75%); mean age was 60.3 years. INTERVENTION: PISCES includes a structured curriculum delivered in three sessions and motivates caregivers to adopt a positive attitude, define problems by obtaining facts, set goals, and generate and evaluate solutions. MEASUREMENTS: Quality of life was measured by the Caregiver Quality of Life Index-Revised; anxiety was measured by the Generalized Anxiety Disorder 7-Item. Other measures included the Caregiver Reaction Assessment scale, demographic data, and an exit interview. RESULTS: Compared with AC, caregivers in the F2F condition had postintervention reduced anxiety (-1.31 [95% confidence interval [CI] = -2.11 to .50]; p = .004) and improved social (.57 [95% CI = .19-.95]; p = .01), financial (.57 [95% CI = .21-.93]; p = .004), and physical quality of life (.53 [95% CI = .19-.87]; p = .01). There were no differences in caregivers in the VC condition compared with the AC condition. CONCLUSION: The PISCES intervention improves caregiver outcomes and is effective when delivered in person. How to integrate technology to reduce the intervention delivery cost warrants further investigation.
RCT Entities:
OBJECTIVES: Family caregivers of hospice patients have multiple needs as they try to cope during a stressful time. Translatable interventions effective in improving caregiver outcomes are greatly needed. Our objective was to assess the impact of a problem-solving intervention (called Problem-Solving Intervention to Support Caregivers in End-of-Life Care Settings [PISCES]) to support hospice caregivers on caregiver quality of life and anxiety, and compare its effectiveness delivered face to face and via videoconferencing. DESIGN: In this 4-year randomized clinical trial, caregivers were randomly assigned to a group receiving standard care with added "friendly calls" (attention control [AC] group), a group receiving standard care and PISCES delivered face to face (F2F), or a group receiving standard care and PISCES delivered via videoconferencing (VC). SETTING: Home hospice. PARTICIPANTS: A total of 514 caregivers participated (172 in AC, 171 in F2F, and 171 in VC). Caregivers were predominantly female (75%); mean age was 60.3 years. INTERVENTION: PISCES includes a structured curriculum delivered in three sessions and motivates caregivers to adopt a positive attitude, define problems by obtaining facts, set goals, and generate and evaluate solutions. MEASUREMENTS: Quality of life was measured by the Caregiver Quality of Life Index-Revised; anxiety was measured by the Generalized Anxiety Disorder 7-Item. Other measures included the Caregiver Reaction Assessment scale, demographic data, and an exit interview. RESULTS: Compared with AC, caregivers in the F2F condition had postintervention reduced anxiety (-1.31 [95% confidence interval [CI] = -2.11 to .50]; p = .004) and improved social (.57 [95% CI = .19-.95]; p = .01), financial (.57 [95% CI = .21-.93]; p = .004), and physical quality of life (.53 [95% CI = .19-.87]; p = .01). There were no differences in caregivers in the VC condition compared with the AC condition. CONCLUSION: The PISCES intervention improves caregiver outcomes and is effective when delivered in person. How to integrate technology to reduce the intervention delivery cost warrants further investigation.
Authors: J Roberts; G Browne; C Milne; L Spooner; A Gafni; M Drummond-Young; J LeGris; S Watt; K LeClair; L Beaumont; J Roberts Journal: Nurs Res Date: 1999 May-Jun Impact factor: 2.381
Authors: Autumn Backhaus; Zia Agha; Melissa L Maglione; Andrea Repp; Bridgett Ross; Danielle Zuest; Natalie M Rice-Thorp; James Lohr; Steven R Thorp Journal: Psychol Serv Date: 2012-05
Authors: Nai-Ching Chi; George Demiris; Frances M Lewis; Amy J Walker; Shelby L Langer Journal: Am J Hosp Palliat Care Date: 2015-07-07 Impact factor: 2.500
Authors: Paul E Ruskin; Michele Silver-Aylaian; Mitchel A Kling; Susan A Reed; Douglas D Bradham; J Richard Hebel; David Barrett; Frederick Knowles; Peter Hauser Journal: Am J Psychiatry Date: 2004-08 Impact factor: 18.112
Authors: Brad G Kurowski; Terry Stancin; H Gerry Taylor; Kelly A McNally; Michael W Kirkwood; Amy Cassedy; Eileen King; McKenna Sklut; Megan E Narad; Shari L Wade Journal: Contemp Clin Trials Commun Date: 2018-04-05
Authors: George Demiris; Karla Washington; Connie M Ulrich; Mihail Popescu; Debra Parker Oliver Journal: Semin Oncol Nurs Date: 2019-06-19 Impact factor: 2.315
Authors: George Demiris; Debra Parker Oliver; Karla T Washington; Chad Chadwick; Jeffrey D Voigt; Sam Brotherton; Mary D Naylor Journal: Int J Med Inform Date: 2022-02-11 Impact factor: 4.046
Authors: George Demiris; Kristin L Corey Magan; Debra Parker Oliver; Karla T Washington; Chad Chadwick; Jeffrey D Voigt; Sam Brotherton; Mary D Naylor Journal: J Am Med Inform Assoc Date: 2020-06-01 Impact factor: 4.497
Authors: Jacquelyn J Benson; Karla T Washington; Robin L Kruse; Debra Parker Oliver; Abigail J Rolbiecki; George Demiris Journal: J Palliat Med Date: 2021-03-10 Impact factor: 2.947